Psychoactive Substance use Disorders: Drugs
The incidence and prevalence of substance use disorders (SUDs) continue to present major costs to individuals, families, and society at large. The DSM-IV (APA, 1994) diagnostic criteria for substance dependence speciies a maladaptive pattern of substance use leading to clinically signiicant impairment or distress as manifested by three (or more) problems occurring at any time in the same 12-month period. An estimated 19.1 million (7.9%) Americans aged 12 or older were current (past month) illicit drug users in 2004. It has been estimated that $484 billion is spent each year on substance abuse–related costs, including treatment and prevention, health care expenditures, lost wages, reduced job production, accidents, and crime, with more than 60% of these costs linked to drugrelated incidents. Aside from the troubling public cost statistics, and as illustrated in the case study below, SUDs are associated with engagement in multiple healthcompromising behaviors (e.g., condom nonuse, multiple partners, exchange of sex for money or drugs) resulting in numerous adverse physical, social, and emotional consequences (Ofice of National Drug Control Policy [ONDCP], 2002; Substance Abuse and Mental Health Services Administration [SAMHSA], 2005).
Was this content written or created while at USF?
Citation / Publisher Attribution
Psychoactive Substance use Disorders: Drugs, in S. M. Turner, M. Hersen & D. C. Beidel (Eds.), Adult Psychopathy and Diagnosis, Hoboken, p. 201-233
Scholar Commons Citation
Daughters, Stacey B.; Bornovalova, Marina; Correia, C.; and Lejuez, Carl W, "Psychoactive Substance use Disorders: Drugs" (2007). Psychology Faculty Publications. 154.